There are also some findings to the contrary: for example, rapamycin can effectively bind to ACSS2 to mitigate the cadmium-decreased levels of ACSS2 and thus inhibit the progression of breast cancer [31,87]. Here, ACSS2 is linked to breast carcinoma.